Navigation Links
Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
Date:12/11/2013

SAN FRANCISCO, Dec. 11, 2013 /PRNewswire/ -- Sutro Biopharma today announced that the company has secured $26 million in a Series D financing. The additional financing will fund the expansion of Sutro's proprietary immuno-oncology product pipeline.  Sutro is developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, utilizing the company's cell-free protein synthesis technology.

The financing closed in December 2013 and was led by Sutro's existing investors: Alta Partners, Amgen Ventures, Celgene Corporation, Lilly Ventures, Skyline Ventures and SV Life Sciences. Sutro has raised over $90 million since its founding in 2003.

"Our ability to accelerate the development of our immuno-oncology portfolio is now in hand. This successful financing further demonstrates the enthusiasm of our investors in Sutro and is a tremendous validation of our emerging product pipeline together with our broad technology platform. Sutro is an emerging leader in the rapid development of novel and differentiated products targeting immuno-oncology pathways," said William Newell, chief executive officer of Sutro Biopharma. "We will continue to advance candidates that leverage the immune system's natural ability to fight cancer, with the goal of establishing next generation immuno-oncology products that will transform cancer therapy for physicians and patients."  

About Sutro Biopharma

Sutro Biopharma, located in South San Francisco, is developing a new generation of antibody drug conjugate therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies. These therapeutics will significantly extend the clinical impact of current oncology therapeutic approaches and are beyond what can be envisioned with current, cell-based expression technologies. Sutro's biochemical synthesis tec
'/>"/>

SOURCE Sutro Biopharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PDL BioPharma Provides Fourth Quarter 2013 Revenue Guidance of $109 Million
2. Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting
3. Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting
4. Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma
5. Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals
6. Roundtable of Biopharma Industry Leaders Offers Insights to Market Access Challenges
7. Global Markets for Bioseparations for Biopharmaceutical Manufacturing to Jump to $6 Billion by 2018
8. Array BioPharma Announces Management Team Change
9. Rapid Delivery Program Product Portfolio Expands to Biopharmaceutical Injectable Market
10. MGB Biopharma Adds its Support to European Antibiotic Awareness Day
11. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 PharmaPoint: Type 1 Diabetes - Global Drug ... 1 diabetes (T1D) is an autoimmune disease that permanently destroys ... body can no longer produce insulin. Over the last 90 ... no other treatment can be offered to a patient who ... with different times of action - long-acting as well as ...
(Date:5/27/2015)... , May 27, 2015  Precision Advisors ( ... findings from its 2015 Digital Trends Study of 145 ... are aware of the concepts of big data and ... them.  The Health Information Technology for ... healthcare providers to make use of electronic medical records ...
(Date:5/27/2015)... May 27, 2015  LumiThera Inc., a developmental ... (PBM) treatment for ocular disorders and disease, announced ... Washington State Life Sciences Discovery Fund (LSDF) ... of the LSDF matching grants worth $500,000 to ... subjects with dry age-related macular degeneration (AMD). ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 NHL ... in the middle of their series against the Anaheim Ducks with ... the Blackhawks can win tonight at home, this will tie up ... at the Honda Center in Anaheim. , During the regular ... Conference as they won the Pacific Division by 8 points ahead ...
(Date:5/27/2015)... Hills, CA (PRWEB) May 27, 2015 Khanna ... of the art web portal focussed on keratoconus eye ... This relentless progressive disease has its onset in the teenage ... down. The cornea or the front clear part of the ... the pressure in the eye. It results in poor vision ...
(Date:5/27/2015)... 2015 Hundreds of Risperdal lawsuits ... individuals who allegedly suffered gynecomastia (male breast growth) ... the antipsychotic drug continue to move forward in ... Philadelphia Court of Common Pleas. According to court ... trial program, as the third trial involving Risperdal’s ...
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
Breaking Medicine News(10 mins):Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3
... -- Scientists who first established a link between obesity ... the intestine now are investigating whether the organisms can ... Washington University School of Medicine in St. Louis, led ... malnourished infants living in Malawi and Bangladesh have a ...
... producer says they may have been mixed in during ... The salmonella contamination behind the recall of 1 ... nuts involved in processing at a California plant, according ... Cohen, production manager for Setton International Foods Inc. of ...
... best rankings had similar death rates to those with the ... task just got harder for patients trying to figure out ... study casts doubt on a hospital safety rating conducted by ... ranked in the highest quartile on the safety survey had ...
... 31, 2009 Formerly depressed women show patterns of ... that are distinctly different from the patterns shown by ... Harvard University. The participants reported being completely well and ... has been observed in depressed individuals in other studies. ...
... Successful Collaboration with the U.S. Army- U.S. FDA (Food ... new vaccine against Japanese Encephalitis for adult travelers and ... a result of an excellent collaboration between Intercell and ... U.S.- Supply contract for IXIARO with the U.S. military, ...
... Two Prestigious AwardsWEST ALLIS, Wis., March 31 /PRNewswire/ ... Center has two new awards among ... top 100 hospitals according to Thomson Reuters, and it ... a role model for others.(Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
Cached Medicine News:Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 2Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 3Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 4Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 2Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 3Health News:Study Casts Doubt on Influential Hospital Safety Survey 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 3Health News:A mother's criticism causes distinctive neural activity among formerly depressed 2Health News:A mother's criticism causes distinctive neural activity among formerly depressed 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Aurora West Allis Medical Center Ranked Among the Top 100 U.S. Hospitals 2
... The ALU-1B Halogen Light source ... light source for routine use in ... has a turret which accepts the ... need for separate adapters. The ALU-1B ...
... Ultrasonic Lithotriptor LUS-2 combines two functions ... procedural performance and cost-efficiency. Boasting a ... helps to minimize hand fatigue for ... calculi while simultaneously removing the fragments ...
... MODULARIS Litho from Siemens Medical Solutions is ... management of stone disease. Urodiagnostics, endourology, lithotripsy, ... may all be part of a urologists ... the complete solution that supports the various ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: